Skip to content

Fast, accurate and easy TB test developed, but concerns about its safety raised

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

Nevirapine hepatotoxicity after treatment switch no more likely at higher CD4 counts

No fat loss with tenofovir after five years

HIV-positive patients have increased risk of side-effects to key drugs used to treat opportunistic infections

Recombinant human growth hormone reduces visceral fat in two randomised studies

One-in-six interrupt treatment within two years of initiating ART

Medication errors common among hospitalised HIV patients